Early discontinuation of antibiotics for febrile neutropenia versus continuation until neutropenia resolution in people with cancer.

People with cancer with febrile neutropenia are at risk of severe infections and mortality and are thus treated empirically with broad-spectrum antibiotic therapy. However, the recommended duration of antibiotic therapy differs across guidelines.